OK-432: An effective sclerosing agent for the treatment of lymphangiomas of head and neck

Kathmandu University Medical Journal

Volumn 5, Issue 19, 2007, Pages 312-317

  Baskota, D K ^a   Singh, B B ^b   Sinha, B K ^b  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

^b TU Teaching Hospital

Author keywords

Head and Neck; Lymphangioma; OK 432; Sclerosing agent; Sclerotherapy

Indexed keywords

PICIBANIL; SCLEROSING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INJECTION SITE EDEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE REACTION; LYMPHANGIOMA; MALE; NEPAL;

EID: 41849141642     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lee Rowe. Congenital anomalies of the head and neck. In: John J. Ballenger eds. Otorhinolaryngology Head & Neck Surgery. Philadelphia, Williams & Wilkins. 1996:210.
2. Milton Waner and CM Bower. Congenital vascular lesions of the head and neck. In: Robin T. Cotton eds. Practical Pediatric otolaryngology. Philadelphia, Lippincott-Raven. 1996:914.
3. Carlos Gonzalez. Tumors of the mouth and pharynx. In: Charles Bluestone eds. Paediatric otolaryngology. Vol.2. Philadelphia, WB Sounders co. 1996:1468.
4. Degenhardt P, Dieckow B, Mau H. Huge intra - and extra thoracic lymphangioma in a baby successfully treated by sclerotherapy with OK-432. Eur J Pedatr Surg. 2006; 16: 197-200.
5. Alonso J, Barbier L, Alvarez J, Romo L, Martin JC, Arteagoitia I et al . OK-432 (picibanil) efficacy in an adult with cystic cervical lymphangioma. A case report. Med Oral Patol Oral Cir Bucal. 2005;10: 362-6.
6. Ogita S, Tsuto T, Nakamura K, Tokiwa K, Iwai N. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg. 1996: 477-80.
7. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg. 1994; 784-5.
8. Luzzatto C, Lo Piccolo R, Fascetti Leon F, Zanon GF, Toffolutti T, Tregnaghi A. Further experience with OK-432 for lymphangioma. Pediatr Surg Int. 2005; 21: 969-72.
9. Bloom DC, Perkins JA, Manning SC. Management of lymphatic malformations. Curr Opin Otolaryngol Head Neck Surg. 2004;12: 500-3.
10. Wheeler JS, Morreau P, Mahadevan M, Pease P. OK -432 and lymphatic malformations in children: the Starship Children's Hospital experience. ANZ J Surg. 2004; 74: 855-8.
11. Banieghbal B, Davies MR. Guidelines for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg. 2003; 13: 103-7.
12. Rautio R, Keski-Nisula L, Laranne J, Laasonen E. Treatment of lymphangiomas with OK-432 (Picibanil). Cardiovasc Intervent Radiol. 2003; 26: 31-6.
13. Giguere CM, Bauman NM, Sato Y, Burke DK, Greinwald JH, Pransky S. et al. Treatment of lymphangiomas with OK-432 (picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg. 2002; 128: 1137-41.
14. Claesson G, Kuylenstierna R. OK-432 therapy for lymphatic malformation in 32 patients (28 children). Int J Pediatr Otorhinolaryngol. 2002; 65:1-6.
15. Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol. 2002; 259: 274-8.
16. Charabi B, Bretlau P, Bille M, Holmelund M. Cystic hygroma of the head and neck-a long term follow-up of 44 cases. Acta Otolaryngol Suppl. 2000; 543: 248-50.
17. Schmidt B, Schimpl G, Hollwarth ME. OK-432 therapy of lymphangiomas in children. Eur J Pediatr. 1996; 155: 649-52.
18. Schel JY, Udassin R, Gozal D, Koplewitz BZ, Dano I, Eliashar R. OK-432 therapy for cervical Lymphangioma. Laryngoscope. 2004; 114: 1805-9